NCT00367965View on ClinicalTrials.gov

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

InsomniaArthritis, Rheumatoid

Interventions

DRUG

Eszopiclone

eszopiclone 3 mg

DRUG

placebo

placebo tablet

Trial Locations (38)

Unknown

Huntsville

Tucson

Santa Maria

Whittier

Danbury

Hamden

Washington D.C.

Aventura

Clearwater

Fort Lauderdale

Ocala

Sarasota

Tampa

Vero Beach

Springfield

Kansas City

Overland Park

Louisville

Fall River

Lansing

St Louis

Medford

Rochester

Winston-Salem

Fargo

Mayfield Village

Oklahoma City

Eugene

Bethlehem

Norristown

West Reading

Columbia

Myrtle Beach

Memphis

Amarillo

Dallas

Lubbock

Everett

All Listed Sponsors

lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00367965 - Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter